Our charity’s Annual General Meeting (AGM) is the year’s most important meeting. It will provide our members with an overview of the organisation’s current position, including its finances, and confirms our mission. To join the AGM event you will need to be a Society member, find out more about joining us by clicking the below […] The post Annual General Meeting 2024 Announced appeared first on The Vitiligo Society ..read more

Sorry, but you do not have permission to view this content. The post How Teachers Can Support Children With Vitiligo appeared first on The Vitiligo Society ..read more

With limited treatment options available for vitiligo, VYN201, developed by VYNE Therapeutics, offers a new avenue of hope. This treatment is currently in Phase 2b trials and uses a new approach to target specific immune system pathways that play a role in vitiligo. Understanding VYN201 VYN201 is classified as a pan-bromodomain BET inhibitor—a type of […] The post Exploring VYN201: A New Hope for Vitiligo Treatment? appeared first on The Vitiligo Society ..read more

INTERnational Consensus on definition of SEverity and relaPse in viTiligo The research team from the Walsall Healthcare & The Royal Wolverhampton NHS Trusts and the University of Birmingham are seeking participants to take part in the INTERCEPT research study. What is the purpose of this research study? The study invites you to share your views […] The post INTERCEPT Study participants required appeared first on The Vitiligo Society ..read more

As I write this, I am sitting in my garden topped up with factor 50 whilst enjoying the warm August weather. We’ve had some pretty hot days on record in the UK and it’s nice to be able to enjoy these moments and see the sun more like a friend than a foe, like I […] The post 4 strategies for embracing vitiligo & the summer appeared first on The Vitiligo Society ..read more

Amidst ongoing research for more effective treatments, Anifrolumab—a drug developed by AstraZeneca—is currently undergoing Phase II clinical trials to evaluate its potential in treating this complex skin condition. Understanding Anifrolumab Anifrolumab is a monoclonal antibody, a type of drug designed to act on specific components within the body’s immune system. It specifically targets IFN-alpha receptor-1 […] The post Anifrolumab: Investigating a new approach for vitiligo treatment appeared first on The Vitiligo Society ..read more

Sorry, but you do not have permission to view this content. The post From Fixed to Growth: How Changing My Mindset Helped Me to Love My Skin appeared first on The Vitiligo Society ..read more

A diagnosis of vitiligo is a significant moment in an individual’s journey, and the experiences surrounding it can vary considerably. While the majority of people first learn about vitiligo through a GP or healthcare professional, their overall experience with the diagnosis is often not reassuring or positive. Patients describe feeling uninformed, unsupported, unheard, distrustful, and/or […] The post Finding a Dermatologist to help treat vitiligo appeared first on The Vitiligo Society ..read more

We are pleased to share that Vitiligo Society Medical and Scientific Panel Member, Dr Viktoria Eleftheriadou has recently established a new vitiligo treatment centre. The Vitiligo Clinical And Research Centre (Vitiligo CARE) will be open to adult and paediatric patients at Walsall Healthcare & The Royal Wolverhampton NHS Trusts. The centre will be conducting clinical research to support the development of new treatments as well as more traditional treatments, as recommended by the British Association of Dermatologists (BAD). Vitiligo CARE is a unique, national vitiligo research c ..read more

We are extremely disappointed that a new drug that could improve the lives of over 1 million sufferers will not be made available through the NHS. The National Institute for Health and Care Excellence (NICE) has announced this week that it will not approve the new drug, Ruxolitinib, for use through the NHS on prescription. We have been advocating for improved treatments for vitiligo since the 1980s and we will continue to fight to ensure that people living with vitiligo will be able to access new treatments, including JAK inhibitor drugs, from the NHS. Frustratingly, this is going to be a ..read more